Clinical Scorecard: Navigating Care for Individuals with Methamphetamine Use Disorder: Results from a Randomized Clinical Study

At a Glance

Key Highlights

• Stimulant-related mortality is a significant public health issue, with methamphetamine implicated in a substantial number of overdose deaths.
• No FDA-approved medications exist for treating methamphetamine use disorder.
• Contingency management is identified as the most effective psychosocial intervention for stimulant use disorders.
• The study compares usual care with a care navigation intervention incorporating contingency management principles.
• The intervention aims to improve treatment linkage following acute care encounters.

Guideline-Based Recommendations

Diagnosis

• Diagnosis of methamphetamine use disorder should consider the intensity and frequency of use.

Management

• Implement contingency management as an evidence-based psychosocial intervention.

Monitoring & Follow-up

• Regular follow-up assessments should be conducted to evaluate treatment engagement and retention.

Risks

• Monitor for acute methamphetamine toxicity, including hypertension, hyperthermia, and neuropsychiatric conditions.

Patient & Prescribing Data

Adults with documented methamphetamine-related acute care encounters

Contingency management is underutilized in addiction treatment programs.

Clinical Best Practices

• Utilize a multidisciplinary team approach in treatment settings.
• Incorporate trauma-informed care principles in interventions.
• Engage patients in developing individualized discharge plans.

Related Resources & Content

• American Society of Addiction Medicine Guidelines
• American Academy of Addiction Psychiatry Guidelines